View Filing Data

3,257

5,478

Long-term marketable investments

4,905

3,595

Other current assets

215

164

Total current assets

15,066

16,039

^[1]

1,167

473

Property, plant, and equipment

27,138

23,672

Intangible assets

339

331

Deferred tax assets

817

1,022

Goodwill

1,228

Other noncurrent assets

533

611

Total assets

46,288

43,376

Liabilities and equity

Accounts payable and accrued expenses

3,494

4,374

Other current liabilities

1,346

859

557

521

Total current liabilities

5,397

5,754

Noncurrent unearned government incentives

3,563

3,777

622

227

Other noncurrent liabilities

417

354

Total liabilities

9,999

10,112

Commitments and contingencies

Redeemable convertible notes

Redeemable noncontrolling interest

Micron shareholders' equity

Common stock, $0.10 par value, 3,000 shares authorized, 1,180 shares issued and 1,104 outstanding (1,170 shares issued and 1,161 outstanding as of August 30, 2018)

118

117

Additional capital

8,217

8,201

Retained earnings

30,201

24,395

Treasury stock, 76 shares held (9 shares as of August 30, 2018)

(3,221)

(429)

Accumulated other comprehensive income

Total Micron shareholders' equity

35,323

32,294

Noncontrolling interests in subsidiaries

867

870

Total equity

36,190

33,164

Total liabilities and equity

$ 46,288

$ 43,376

[1]	The maturities of long-term marketable securities range from one to four years.

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Millions	May 30, 2019	Aug. 30, 2018
Liabilities and equity
Common Stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common Stock, authorized shares (in shares)	3,000	3,000
Common Stock, issued (in shares)	1,180	1,170
Common Stock, outstanding (in shares)	1,104	1,161
Treasury Stock, held (in shares)	76	9

STATEMENT OF CHANGES IN EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Total Micron Shareholders' Equity	Noncontrolling Interests in Subsidiaries
Balance (in shares) at Aug. 31, 2017		1,116
Balance at Aug. 31, 2017	$ 19,470	$ 112	$ 8,287	$ 10,260	$ (67)	$ 29	$ 18,621	$ 849
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,678			2,678			2,678	0
Other comprehensive income (loss), net	(5)					(5)	(5)
Contributions from noncontrolling interests	18							18
Stock issued in public offering (in shares)		34
Stock issued in public offering	1,366	$ 3	1,363				1,366
Stock issued under stock plans (in shares)		9
Stock issued under stock plans	106	$ 1	105				106
Stock-based compensation expense	51		51				51
Repurchase of stock (in shares)		(1)
Repurchase of stock	(90)	$ 0	(90)		0		(90)
Reclassification of redeemable convertible notes, net	3		3				3
Conversion of convertible notes	(204)		(271)				(204)
Treasury stock reissued to settle conversion and repurchase of convertible notes					67
Balance (in shares) at Nov. 30, 2017		1,158
Balance at Nov. 30, 2017	23,393	$ 116	9,448	12,938	0	24	22,526	867
Balance (in shares) at Aug. 31, 2017		1,116
Balance at Aug. 31, 2017	19,470	$ 112	8,287	10,260	(67)	29	18,621	849
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	9,812
Other comprehensive income (loss), net	(7)
Balance (in shares) at May. 31, 2018		1,169
Balance at May. 31, 2018	29,518	$ 117	8,869	20,070	(429)	22	28,649	869
Balance (in shares) at Nov. 30, 2017		1,158
Balance at Nov. 30, 2017	23,393	$ 116	9,448	12,938	0	24	22,526	867
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,311			3,309			3,309	2
Other comprehensive income (loss), net	19					19	19
Stock issued under stock plans (in shares)		8
Stock issued under stock plans	82	$ 0	82				82
Stock-based compensation expense	52		52				52
Repurchase of stock (in shares)		(1)
Repurchase of stock	(44)	$ 0	(44)		0		(44)
Settlement of capped calls	0		313		(313)		0
Reclassification of redeemable convertible notes, net	5		5				5
Conversion of convertible notes	(252)		(252)				(252)
Balance (in shares) at Mar. 01, 2018		1,165
Balance at Mar. 01, 2018	26,566	$ 116	9,604	16,247	(313)	43	25,697	869
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,823			3,823			3,823	0
Other comprehensive income (loss), net	(21)					(21)	(21)
Stock issued under stock plans (in shares)		4
Stock issued under stock plans	82	$ 1	81				82
Stock-based compensation expense	48		48				48
Repurchase of stock (in shares)		0
Repurchase of stock	(4)	$ 0	(4)		0		(4)
Settlement of capped calls	0		116		(116)		0
Reclassification of redeemable convertible notes, net	9		9				9
Conversion of convertible notes	(985)		(985)				(985)
Balance (in shares) at May. 31, 2018		1,169
Balance at May. 31, 2018	$ 29,518	$ 117	8,869	20,070	(429)	22	28,649	869
Balance (in shares) at Aug. 30, 2018	1,170	1,170
Balance at Aug. 30, 2018	$ 33,164	$ 117	8,201	24,395	(429)	10	32,294	870
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (excluding redeemable noncontrolling interest)	3,293			3,293			3,293	0
Other comprehensive income (loss), net	(15)					(15)	(15)
Stock issued under stock plans (in shares)		3
Stock issued under stock plans	15	$ 0	15				15
Stock-based compensation expense	61		61				61
Repurchase of stock (in shares)		(1)
Repurchase of stock		$ 0		(11)
Accelerated share repurchase program			108
Repurchase of stock					(1,933)
Repurchase of stock (held and retired)	(1,836)						(1,836)
Reclassification of redeemable convertible notes, net	1		1				1
Conversion of convertible notes	(36)		(36)				(36)
Balance (in shares) at Nov. 29, 2018		1,172
Balance at Nov. 29, 2018	$ 34,739	$ 117	8,350	27,769	(2,362)	(5)	33,869	870
Balance (in shares) at Aug. 30, 2018	1,170	1,170
Balance at Aug. 30, 2018	$ 33,164	$ 117	8,201	24,395	(429)	10	32,294	870
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,772
Other comprehensive income (loss), net	(2)
Conversion of convertible notes	$ (377)
Balance (in shares) at May. 30, 2019	1,180	1,180
Balance at May. 30, 2019	$ 36,190	$ 118	8,217	30,201	(3,221)	8	35,323	867
Balance (in shares) at Nov. 29, 2018		1,172
Balance at Nov. 29, 2018	34,739	$ 117	8,350	27,769	(2,362)	(5)	33,869	870
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (excluding redeemable noncontrolling interest)	1,624			1,619			1,619	5
Other comprehensive income (loss), net	11					11	11
Stock issued under stock plans (in shares)		7
Stock issued under stock plans	77	$ 1	76				77
Stock-based compensation expense	57		57				57
Repurchase of stock (in shares)		(1)
Repurchase of stock		$ 0	(5)	(24)
Repurchase of stock					(702)
Repurchase of stock (held and retired)	(731)						(731)
Acquisitions of noncontrolling interest	(12)						0	(12)
Reclassification of redeemable convertible notes, net	1		1				1
Conversion of convertible notes	(336)		(336)				(336)
Balance (in shares) at Feb. 28, 2019		1,178
Balance at Feb. 28, 2019	35,430	$ 118	8,143	29,364	(3,064)	6	34,567	863
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (excluding redeemable noncontrolling interest)	849			840			840	9
Net income	851
Other comprehensive income (loss), net	2					2	2
Stock issued under stock plans (in shares)		2
Stock issued under stock plans	20	$ 0	20				20
Stock-based compensation expense	58		58				58
Repurchase of stock (in shares)		0
Repurchase of stock		$ 0	0	(3)
Repurchase of stock					(157)
Repurchase of stock (held and retired)	(160)						(160)
Acquisitions of noncontrolling interest	(4)		1				1	(5)
Conversion of convertible notes	$ (5)		(5)				(5)
Balance (in shares) at May. 30, 2019	1,180	1,180
Balance at May. 30, 2019	$ 36,190	$ 118	$ 8,217	$ 30,201	$ (3,221)	$ 8	$ 35,323	$ 867

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	May 30, 2019	May 31, 2018
Cash flows from operating activities
Net income	$ 5,772	$ 9,812
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation expense and amortization of intangible assets	4,008	3,474
Amortization of debt discount and other costs	39	78
Loss on debt prepayments, repurchases, and conversions	386	386
Stock-based compensation	176	151
Change in operating assets and liabilities
Receivables	2,373	(1,177)
Inventories	(1,315)	(246)
Accounts payable and accrued expenses	(703)	151
Deferred income taxes, net	195	(216)
Other	25	(168)
Net cash provided by operating activities	10,956	12,245
Cash flows from investing activities
Expenditures for property, plant, and equipment	(7,752)	(6,628)
Purchases of available-for-sale securities	(3,814)	(606)
Proceeds from sales of available-for-sale securities	1,271	569
Proceeds from government incentives	668	171
Proceeds from maturities of available-for-sale securities	626	219
Other	16	188
Net cash provided by (used for) investing activities	(8,985)	(6,087)
Cash flows from financing activities
Payments to acquire treasury stock	(2,727)	(69)
Repayments of debt	(2,376)	(6,767)
Payments on equipment purchase contracts	(54)	(170)
Proceeds from issuance of debt	1,800	969
Proceeds from issuance of stock	112	1,636
Other	(85)	(42)
Net cash provided by (used for) financing activities	(3,330)	(4,443)
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash	6	(4)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(1,353)	1,711
Cash, cash equivalents, and restricted cash at beginning of period	6,587	5,216
Cash, cash equivalents, and restricted cash at end of period	$ 5,234	$ 6,927

Basis of Presentation	9 Months Ended
Basis of Presentation	May 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 30, 2018, except for changes related to recently adopted accounting standards. See "Recently Adopted Accounting Standards" note. Prior year information is presented in accordance with the accounting guidance in effect during that period and has not been recast for recently adopted accounting standards. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to fairly state the financial information set forth herein. Certain reclassifications have been made to prior period amounts to conform to current period presentation. Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2019 and 2018 each contain 52 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 30, 2018.

Variable Interest Entities	9 Months Ended
Variable Interest Entities	May 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	Variable Interest Entities We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments. Unconsolidated VIEs PTI Xi'an: Powertech Technology Inc. Xi'an ("PTI Xi'an") is a wholly-owned subsidiary of Powertech Technology Inc. ("PTI") and was created to provide assembly services to us at our manufacturing site in Xi'an, China. We do not have an equity interest in PTI Xi'an. PTI Xi'an is a VIE because of the terms of its service agreement with us and its dependency on PTI to finance its operations. We do not have the power to direct the activities of PTI Xi'an that most significantly impact its economic performance, primarily because we do not have governance rights. Therefore, we do not consolidate PTI Xi'an. In connection with our assembly services with PTI, as of May 30, 2019 and August 30, 2018, we had net property, plant, and equipment of $53 million and $63 million, respectively, and capital lease obligations of $51 million and $63 million, respectively. Consolidated VIE IMFT: IMFT is a VIE because all of its costs are passed to us and its other member, Intel, through product purchase agreements and because IMFT is dependent upon us or Intel for additional cash requirements. The primary activities of IMFT are driven by the constant introduction of product and process technology. Because we perform a significant majority of the technology development, we have the power to direct its key activities. We consolidate IMFT because we have the power to direct the activities of IMFT that most significantly impact its economic performance and because we have the obligation to absorb losses and the right to receive benefits from IMFT that could potentially be significant to it. In January 2019, we exercised our option to acquire Intel's interest in IMFT and, in the third quarter of 2019, Intel set the closing date to occur on October 31, 2019. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.)

Recently Adopted Accounting Standards

9 Months Ended

May 30, 2019

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Recently Adopted Accounting Standards

In October 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-16 – Intra-Entity Transfers Other Than Inventory ("ASU 2016-16"), which requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. We adopted this ASU in the first quarter of 2019 under the modified retrospective method and, in connection therewith, made certain adjustments as noted in the table below.

In January 2016, the FASB issued ASU 2016-01 – Recognition and Measurement of Financial Assets and Financial Liabilities, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. We adopted this ASU in the first quarter of 2019 under the modified retrospective method, with prospective adoption for amendments related to equity securities without readily determinable fair values. The adoption of this ASU did not have a material impact on our financial statements.

In May 2014, the FASB issued ASU 2014-09 – Revenue from Contracts with Customers (as amended, "ASC 606"), which supersedes nearly all existing revenue recognition guidance under generally accepted accounting principles in the United States. The core principal of ASC 606 is that an entity should recognize revenue when it transfers control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASC 606 also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. We adopted ASC 606 in the first quarter of 2019 under the modified retrospective method and, in connection therewith, made certain adjustments as noted in the table below. We applied ASC 606 to contracts with customers that had not yet been completed as of the adoption date.

The following table summarizes the effects of adopting ASU 2016-16 and ASC 606:




	Ending Balance as of August 30, 2018		ASU 2016-16			ASC 606			Opening Balance as of August 31, 2018
Receivables	$	5,478	$	—		$	114		$	5,592
Inventories	3,595		—			(5		)	3,590
Other current assets	164		(14		)	30			180
Deferred tax assets	1,022		56			(92		)	986
Other current liabilities	521		—			(4		)	517
Other noncurrent liabilities	354		—			1			355
Retained earnings	24,395		42			50			24,487

As a result of the adoption of ASC 606, the opening balances as of August 31, 2018 for receivables, other current assets, and other current liabilities increased due to the reclassification of allowances for rebates, pricing adjustments, and returns to conform to the new presentation requirements. In addition, the margin from previously deferred sales to distributors was reclassified from other current liabilities to retained earnings. The tax effects of the adoption of ASC 606 were recorded primarily as a reduction of net deferred tax assets, substantially as a result of recognizing income for accounting purposes earlier under ASC 606 than for tax purposes in various jurisdictions.

The effects of ASC 606 to our consolidated statement of operations and balance sheet were as follows:



	Quarter ended May 30, 2019									Nine months ended May 30, 2019
	As Reported			Adjustments			Amounts Without the Effects of Adoption of ASC 606			As Reported			Adjustments			Amounts Without the Effects of Adoption of ASC 606
Revenue	$	4,788		$	43		$	4,831		$	18,536		$	(72	)	$	18,464
Cost of goods sold	2,960			4			2,964			9,229			(65		)	9,164
Interest expense	(29		)	2			(27		)	(89		)	5			(84		)
Income tax (provision) benefit	135			(8		)	127			(622		)	(13		)	(635		)
Net income attributable to Micron	840			33			873			5,752			(15		)	5,737



As of May 30, 2019	As Reported		Adjustments			Amounts Without the Effects of Adoption of ASC 606
Receivables	$	3,257	$	(112	)	$	3,145
Other current assets	215		(41		)	174
Deferred tax assets	817		82			899
Accounts payable and accrued expenses	3,494		3			3,497
Other current liabilities	557		(8		)	549
Other noncurrent liabilities	417		(1		)	416
Retained earnings	30,201		(65		)	30,136

Recently Issued Accounting Standards Not Yet Adopted	9 Months Ended
Recently Issued Accounting Standards Not Yet Adopted	May 30, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Issued Accounting Standards Not Yet Adopted	Recently Issued Accounting Standards Not Yet Adopted In November 2018, the FASB issued ASU 2018-18 – Collaborative Arrangements, which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue when the collaborative arrangement participant is a customer in the context of a unit of account and precludes recognizing as revenue consideration received from a collaborative arrangement participant if the participant is not a customer. This ASU will be effective for us in the first quarter of 2021 with early adoption permitted. This ASU requires retrospective adoption to the date we adopted ASC 606, August 31, 2018, by recognizing a cumulative-effect adjustment to the opening balance of retained earnings of the earliest annual period presented. We are evaluating the timing and effects of our adoption of this ASU on our financial statements. In June 2016, the FASB issued ASU 2016-13 – Measurement of Credit Losses on Financial Instruments, which requires a financial asset (or a group of financial assets) measured on the basis of amortized cost to be presented at the net amount expected to be collected. This ASU requires that the income statement reflect the measurement of credit losses for newly recognized financial assets as well as the increases or decreases of expected credit losses that have taken place during the period. This ASU requires that credit losses of debt securities designated as available-for-sale be recorded through an allowance for credit losses and limits the credit loss to the amount by which fair value is below amortized cost. This ASU will be effective for us in the first quarter of 2021 with adoption permitted as early as the first quarter of 2020. This ASU requires modified retrospective adoption, with prospective adoption for debt securities for which an other-than-temporary impairment had been recognized before the effective date. We are evaluating the timing and effects of our adoption of this ASU on our financial statements. In February 2016, the FASB issued ASU 2016-02 – Leases, which amends a number of aspects of lease accounting, including requiring lessees to recognize operating leases with a term greater than one year on their balance sheet as a right-of-use asset and corresponding liability, measured at the present value of lease payments. This ASU, as amended, will be effective for us in the first quarter of 2020 with early adoption permitted and allows for either a modified retrospective adoption or a retrospective adoption by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The adoption of this ASU will result in an increase to our consolidated balance sheets for these right-of-use assets and corresponding liabilities. We are evaluating the timing and other effects of our adoption of this ASU on our financial statements.

Cash and Investments

9 Months Ended

May 30, 2019

Investments [Abstract]

Cash and Investments

All of our marketable debt and equity investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	May 30, 2019								August 30, 2018
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	3,171	$	—	$	—	$	3,171	$	3,223	$	—	$	—	$	3,223
Level 1⁽²⁾
Money market funds	1,208		—		—		1,208		2,443		—		—		2,443
Level 2⁽³⁾
Certificates of deposit	732		749		5		1,486		806		11		2		819
Corporate bonds	—		516		704		1,220		3		172		272		447
Government securities	11		131		200		342		5		63		103		171
Asset-backed securities	—		83		258		341		—		34		96		130
Commercial paper	35		53		—		88		26		16		—		42
	5,157		$	1,532	$	1,167	$	7,856	6,506		$	296	$	473	$	7,275
Restricted cash⁽⁴⁾	77								81
Cash, cash equivalents, and restricted cash	$	5,234							$	6,587


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾

The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analyses to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of May 30, 2019 or August 30, 2018.


⁽⁴⁾	Restricted cash is included in other noncurrent assets and primarily consisted of balances related to the MMJ Creditor Payments. The restrictions on the MMJ Creditor Payments lapse upon approval by the trustees and/or Tokyo District Court.

Gross realized gains and losses from sales of available-for-sale securities were not material for any period presented. As of May 30, 2019, there were no available-for-sale securities that had been in a loss position for longer than 12 months.

Receivables

9 Months Ended

May 30, 2019

Receivables [Abstract]



As of	May 30, 2019		August 30, 2018
Trade receivables	$	2,848	$	5,056
Income and other taxes	202		161
Other	207		261
	$	3,257	$	5,478

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details

Inventories

9 Months Ended

May 30, 2019

Inventory Disclosure [Abstract]

Property, Plant and Equipment [Abstract]



As of	May 30, 2019		August 30, 2018
Finished goods	$	853	$	815
Work in process	3,537		2,357
Raw materials and supplies	515		423
	$	4,905	$	3,595

Property, Plant, and Equipment

9 Months Ended

May 30, 2019

Property, Plant, and Equipment



As of	May 30, 2019			August 30, 2018
Land	$	352		$	345
Buildings	10,167			8,680
Equipment⁽¹⁾	42,626			38,249
Construction in progress⁽²⁾	1,893			1,162
Software	767			655
	55,805			49,091
Accumulated depreciation	(28,667		)	(25,419		)
	$	27,138		$	23,672


⁽¹⁾	Included costs related to equipment not placed into service of $2.24 billion and $1.73 billion, as of May 30, 2019 and August 30, 2018, respectively.


⁽²⁾	Included building-related construction, tool installation, and software costs for assets not yet placed into service.

Intangible Assets and Goodwill

9 Months Ended

May 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill



As of	May 30, 2019					August 30, 2018
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Amortizing assets
Product and process technology	$	574	$	(235	)	$	567	$	(344	)
Non-amortizing assets
In-process R&D	—		—			108		—

Total intangible assets	$	574	$	(235	)	$	675	$	(344	)

Goodwill	$	1,228				$	1,228

In the first nine months of 2019 and 2018, we capitalized $71 million and $27 million, respectively, for product and process technology with weighted-average useful lives of 8 years and 11 years, respectively, and placed in service $108 million of in-process R&D in the first quarter of 2019, which is being amortized on a straight-line basis over six years. Expected amortization expense is $18 million for the remainder of 2019, $68 million for 2020, $59 million for 2021, $48 million for 2022, and $43 million for 2023.

Accounts Payable and Accrued Expenses

9 Months Ended

May 30, 2019

Payables and Accruals [Abstract]

Accounts Payable and Accrued Expenses



As of	May 30, 2019		August 30, 2018
Accounts payable	$	1,336	$	1,692
Property, plant, and equipment payables	1,160		1,238
Salaries, wages, and benefits	565		841
Income and other taxes	254		402
Other	179		201
	$	3,494	$	4,374

Debt

9 Months Ended

May 30, 2019

Debt Disclosure [Abstract]

Debt



As of	May 30, 2019										August 30, 2018
					Net Carrying Amount						Net Carrying Amount
Instrument	Stated Rate		Effective Rate		Current		Long-Term		Total		Current		Long-Term		Total
IMFT Member Debt⁽¹⁾	N/A		N/A		$	858	$	—	$	858	$	—	$	1,009	$	1,009
Capital lease obligations	N/A		4.20	%	233		415		648		310		536		846
MMJ Creditor Payments	N/A		9.76	%	187		—		187		309		183		492
2022 Term Loan B	4.24	%	4.65	%	5		716		721		5		720		725
2024 Notes	4.64	%	4.76	%	—		597		597		—		—		—
2025 Notes	5.50	%	5.56	%	—		516		516		—		515		515
2026 Notes	4.98	%	5.07	%	—		497		497		—		—		—
2029 Notes	5.33	%	5.40	%	—		696		696		—		—		—
2032D Notes	3.13	%	6.33	%	—		126		126		—		132		132
2033F Notes	2.13	%	4.93	%	63		—		63		235		—		235
2043G Notes	3.00	%	6.76	%	—		—		—		—		682		682
					$	1,346	$	3,563	$	4,909	$	859	$	3,777	$	4,636


⁽¹⁾	IMFT Member Debt was classified as current as of May 30, 2019 as a result of exercising our option to acquire Intel's interest in IMFT.

Senior Unsecured Notes

On February 6, 2019, we issued our 2024 Notes, 2026 Notes, and 2029 Notes in a public offering. Issuance costs for these notes were $11 million. We may redeem some or all of these notes at our option prior to their maturity at a redemption price equal to accrued interest plus the present value of the remaining scheduled payments and we may redeem some or all of these notes at par between one and three months prior to maturity.

Each of the 2024 Notes, 2026 Notes, and 2029 Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries (which are generally domestic subsidiaries in which we own at least 80% of the voting stock) to (1) create or incur certain liens, (2) enter into certain sale and lease-back transactions; and (3) consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations and exceptions. Additionally, if a change in control triggering event occurs, as defined in the indenture governing such notes, we will be required to offer to purchase such notes at 101% of the outstanding aggregate principal amount plus accrued interest up to the purchase date.

Convertible Senior Notes

On February 8, 2019, we notified holders of our 2043G Notes that we would redeem all of the outstanding 2043G Notes on March 13, 2019. Holders could elect to convert these notes prior to March 12, 2019 at a conversion rate of 34.2936 shares of our common stock per $1,000 of principal amount. In connection with our notice, we made an irrevocable election to settle any conversions in cash and, as a result, we reclassified $336 million from equity to a derivative debt liability. Holders converted substantially all of the 2043G Notes and, on March 13, 2019, we paid $1.43 billion to settle the conversions. We incurred losses of $316 million and $84 million in the third and second quarters of 2019, respectively, in connection with these transactions.

Holders of our convertible notes may convert their notes during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price. As of May 30, 2019, the trading price of our common stock was higher than the conversion prices of our 2032D Notes and our 2033F Notes and, as a result, the aggregate conversion value of $641 million exceeded the aggregate principal amount of $198 million by $443 million.

Available Revolving Credit Facility

On November 27, 2018, we increased the amount available to draw under our existing revolving credit facility expiring in July 2023 from $2.0 billion to $2.5 billion. As of May 30, 2019, there were no outstanding amounts drawn under this facility.

Debt Activity

When we receive a notice of conversion for any of our convertible notes and elect to settle in cash any portion of the conversion obligation in excess of the principal amount, the cash settlement obligations become derivative debt liabilities subject to mark-to-market accounting treatment based on the volume-weighted-average price of our common stock over a period of 20 consecutive trading days. Accordingly, at the date of our election to settle a conversion in cash, we reclassify the fair value of the equity component of the converted notes from additional capital to derivative debt liability within current debt in our consolidated balance sheet.

The following table presents the effects of conversions, settlements, and issuance of debt in the first nine months of 2019:



Nine months ended May 30, 2019	Increase (Decrease) in Principal			Increase (Decrease) in Carrying Value			Increase (Decrease) in Cash			Decrease in Equity			Gain (Loss)
Settled conversions
2032D Notes	$	(10	)	$	(9	)	$	(35	)	$	(28	)	$	2
2033F Notes	(43		)	(173		)	(184		)	(23		)	12
2043G Notes	(1,019		)	(691		)	(1,426		)	(326		)	(400		)
Issuances
2024 Notes	600			597			597			—			—
2026 Notes	500			497			497			—			—
2029 Notes	700			695			695			—			—
	$	728		$	916		$	144		$	(377	)	$	(386	)

Contingencies	9 Months Ended
Contingencies	May 30, 2019
Loss Contingency [Abstract]
Contingencies	Contingencies We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations, or financial condition. Patent Matters As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights. On August 12, 2014, MLC Intellectual Property, LLC ("MLC") filed a patent infringement action against Micron in the United States District Court for the Northern District of California. The complaint alleges that Micron infringes a single U.S. patent and seeks damages, attorneys' fees, and costs. The matter is scheduled for trial beginning on August 12, 2019. On November 21, 2014, Elm 3DS Innovations, LLC ("Elm") filed a patent infringement action against Micron; Micron Semiconductor Products, Inc.; and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe 13 U.S. patents and seeks damages, attorneys' fees, and costs. On December 15, 2014, Innovative Memory Solutions, Inc. ("IMS") filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND products infringe eight U.S. patents and seeks damages, attorneys' fees, and costs. On July 23, 2018, IMS served a patent infringement complaint on Micron Semiconductor (Deutschland) GmbH and Micron Europe Limited alleging that products including our SSDs infringe a European patent. The complaint seeks unspecified damages and an order forbidding Micron Semiconductor (Deutschland) GmbH and Micron Europe Limited from offering to sell, using, and importing the accused products. On August 31, 2018, Micron was served with a complaint filed by IMS in Shenzhen Intermediate People's Court in Guangdong Province, China. The complaint alleges that certain of our NAND flash products infringe a Chinese patent. The complaint seeks an order requiring Micron to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 1 million Chinese yuan plus expenses. On March 19, 2018, Micron Semiconductor (Xi'an) Co., Ltd. ("MXA") was served with a patent infringement complaint filed by Fujian Jinhua Integrated Circuit Co., Ltd. ("Jinhua") in the Fuzhou Intermediate People's Court in Fujian Province, China (the "Fuzhou Court"). On April 3, 2018, Micron Semiconductor (Shanghai) Co. Ltd. ("MSS") was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 98 million Chinese yuan plus court fees incurred. On March 21, 2018, MXA was served with a patent infringement complaint filed by United Microelectronics Corporation ("UMC") in the Fuzhou Court. On April 3, 2018, MSS was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 90 million Chinese yuan plus court fees incurred. On April 3, 2018, MSS was served with another patent infringement complaint filed by Jinhua and two additional complaints filed by UMC in the Fuzhou Court. The three additional complaints allege that MSS infringes three Chinese patents by manufacturing and selling certain Crucial MX300 SSDs and certain GDDR5 memory chips. The two complaints filed by UMC each seek an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages for each complaint of 90 million Chinese yuan plus court fees incurred. The complaint filed by Jinhua seeks an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 98 million Chinese yuan plus court fees incurred. On October 9, 2018, UMC withdrew its complaint that alleged MSS infringed a Chinese patent by manufacturing and selling certain GDDR5 memory chips. On July 5, 2018, MXA and MSS were notified that the Fuzhou Court granted a preliminary injunction against those entities that enjoins them from manufacturing, selling, or importing certain Crucial and Ballistic-branded DRAM modules and solid-state drives in China. The affected products make up slightly more than 1% of our annualized revenues. We are complying with the ruling and have requested the Fuzhou Court to reconsider or stay its decision. Among other things, the above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for a significant portion of our revenue. Qimonda On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda's insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void, under Section 133 of the German Insolvency Act, a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008, pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera (the "Inotera Shares"), representing approximately 18% of Inotera's outstanding shares as of May 30, 2019, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate, under Sections 103 or 133 of the German Insolvency Code, a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the court issued judgments: (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera Shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on the Inotera Shares and all other benefits; (4) denying Qimonda's claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are canceled. In addition, the court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by Micron B.V. and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by Micron B.V. from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court. Antitrust Matters On April 27, 2018, a complaint was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California. Subsequently two substantially identical cases were filed in the same court. The lawsuits purport to be on behalf of a nationwide class of indirect purchasers of DRAM products. The complaints assert claims based on alleged price-fixing of DRAM products under federal and state law during the period from June 1, 2016 to February 1, 2018, and seek treble monetary damages, costs, interest, attorneys' fees, and other injunctive and equitable relief. On June 26, 2018, a complaint was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California. Subsequently four substantially identical cases were filed in the same court. The lawsuits purport to be on behalf of a nationwide class of direct purchasers of DRAM products. The complaints assert claims based on alleged price-fixing of DRAM products under federal and state law during the period from June 1, 2016 to February 1, 2018, and seek treble monetary damages, costs, interest, attorneys' fees, and other injunctive and equitable relief. Additionally, six cases have been filed in the following Canadian courts: Superior Court of Quebec, the Federal Court of Canada, the Ontario Superior Court of Justice, and the Supreme Court of British Columbia. The substantive allegations in these cases are similar to those asserted in the cases filed in the United States. On May 15, 2018, the Chinese State Administration for Market Regulation ("SAMR") notified Micron that it was investigating potential collusion and other anticompetitive conduct by DRAM suppliers in China. On May 31, 2018, SAMR made unannounced visits to our sales offices in Beijing, Shanghai, and Shenzhen to seek certain information as part of its investigation. We are cooperating with SAMR in its investigation. Securities Matters On January 23, 2019, a complaint was filed against Micron and two of our officers, Sanjay Mehrotra and David Zinsner, in the U.S. District Court for the Southern District of New York. The lawsuit purports to be brought on behalf of a class of purchasers of our stock during the period from June 22, 2018 through November 19, 2018. Subsequently two substantially similar cases were filed in the same court adding one of our former officers, Ernie Maddock, as a defendant and alleging a class action period from September 26, 2017 through November 19, 2018. The separate cases were joined, and a consolidated amended complaint was filed on June 15, 2019. The consolidated amended complaint alleges that defendants committed securities fraud through misrepresentations and omissions about purported anticompetitive behavior in the DRAM industry and seek compensatory and punitive damages, fees, interest, costs, and other appropriate relief. On March 5, 2019, a shareholder derivative complaint was filed in the U.S. District Court for the District of Delaware, allegedly on behalf of and for the benefit of Micron, against certain current and former officers and directors of Micron for alleged breaches of their fiduciary duties and other violations of law. The allegations are based on, among other things, purported false and misleading statements regarding anticompetitive behavior in the DRAM industry. The complaint seeks damages, fees, interest, costs, and other appropriate relief. Other On December 5, 2017, Micron filed a complaint against UMC and Jinhua in the U.S. District Court for the Northern District of California. The complaint alleges that UMC and Jinhua violated the Defend Trade Secrets Act, the civil provisions of the Racketeer Influenced and Corrupt Organizations Act, and California's Uniform Trade Secrets Act by misappropriating Micron's trade secrets and other misconduct. Micron's complaint seeks damages, restitution, disgorgement of profits, injunctive relief, and other appropriate relief. On June 13, 2019, current Micron employee Chris Manning filed a putative class action lawsuit on behalf of Micron employees subject to the Idaho Claim Act who earned a performance-based bonus after the conclusion of fiscal year 2018 whose performance rating was calculated based upon a mandatory percentage distribution range of performance ratings. On behalf of himself and the putative class, Manning asserts claims for violation of the Idaho Wage Claim Act, breach of contract, breach of the covenant of good faith and fair dealing, and fraud. In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition. We are unable to predict the outcome of the patent matters, the Qimonda matter, antitrust matters, securities matters, and other matters noted above and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing, as well as the resolution of any other legal matter noted above, could have a material adverse effect on our business, results of operations, or financial condition.

Equity

9 Months Ended

May 30, 2019

Equity [Abstract]

Equity

Micron Shareholders' Equity

Common Stock Repurchases: Our Board of Directors has authorized the discretionary repurchase of up to $10 billion of our outstanding common stock beginning in our fiscal 2019. We may purchase shares on a discretionary basis through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans, subject to market conditions and our ongoing determination of the best use of available cash. The repurchase authorization does not obligate us to acquire any common stock.

In the third quarter and first nine months of 2019, we repurchased 4 million shares of our common stock for $157 million and 67 million shares of our common stock for $2.66 billion, respectively, under an accelerated share repurchase agreement, Rule 10b5-1 plans, and through open market repurchases. The shares were recorded as treasury stock.

Noncontrolling Interests in Subsidiaries



As of	May 30, 2019				August 30, 2018
	Balance		Percentage		Balance		Percentage
IMFT	$	867	49	%	$	853	49	%
Other	—		—		17		Various
	$	867			$	870

IMFT: Since 2006, we have owned 51% of IMFT, a joint venture between us and Intel. IMFT is governed by a Board of Managers, for which the number of managers appointed by each member varies based on the members' respective ownership interests. IMFT manufactures semiconductor products exclusively for its members under a long-term supply agreement at prices approximating cost. In the first quarter of 2018, IMFT discontinued production of NAND and subsequent to that time has manufactured 3D XPoint memory. In the fourth quarter of 2018, we announced that we and Intel will no longer jointly develop 3D XPoint technology beyond the second generation. We expect development of the second generation of 3D XPoint technology to be substantially completed in the first quarter of 2020. IMFT sales to Intel were $184 million and $531 million for the third quarter and first nine months of 2019, respectively, and were $114 million and $341 million for the third quarter and first nine months of 2018, respectively.

In January 2019, we exercised our option to acquire Intel's interest in IMFT and, in the third quarter of 2019, Intel set the closing date to occur on October 31, 2019. At closing, we expect to pay Intel approximately $1.4 billion in cash for Intel's noncontrolling interest in IMFT and IMFT Member Debt. As of May 30, 2019, current debt included $858 million of IMFT Member Debt. Subsequent to setting the closing date, Intel notified us of its election to receive supply from IMFT from the closing date through April 2020 at a volume equal to approximately 50% of their volume from IMFT in the six-month period prior to closing.

IMFT's capital requirements are generally determined based on an annual plan approved by the members, and capital contributions to IMFT are requested as needed. Capital requests are made to the members in proportion to their then-current ownership interest. Members may elect to not contribute their proportional share, and in such event, the contributing member may elect to contribute any amount of the capital request, either in the form of an equity contribution or member debt financing. Under the supply agreement, the members have rights and obligations to the capacity of IMFT in proportion to their investment, including member debt financing. Any capital contribution or member debt financing results in a proportionate adjustment to

the sharing of output on an eight-month lag. Members pay their proportionate share of fixed costs associated with IMFT's capacity.

Creditors of IMFT have recourse only to IMFT's assets and do not have recourse to any other of our assets. The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:



As of	May 30, 2019		August 30, 2018
Assets
Cash and equivalents	$	184	$	91
Receivables	125		126
Inventories	122		114
Other current assets	5		8
Total current assets	436		339
Property, plant, and equipment	2,352		2,641
Other noncurrent assets	37		45
Total assets	$	2,825	$	3,025

Liabilities
Accounts payable and accrued expenses	$	106	$	138
Current debt	865		20
Other current liabilities	41		9
Total current liabilities	1,012		167
Long-term debt	54		1,064
Other noncurrent liabilities	23		74
Total liabilities	$	1,089	$	1,305

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Fair Value Measurements

9 Months Ended

May 30, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements

The estimated fair values of our convertible and other notes in the table below were determined based on Level 2 inputs, and together with the carrying value of our outstanding debt instruments (excluding the carrying value of equity and mezzanine equity components of our convertible notes) were as follows:



As of	May 30, 2019				August 30, 2018
	Fair Value		Carrying Value		Fair Value		Carrying Value
Notes and MMJ Creditor Payments	$	4,165	$	4,072	$	2,798	$	2,741
Convertible notes	643		189		3,124		1,049

Derivative Instruments and Hedging Activities Disclosure [Abstract]

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Derivative Instruments

9 Months Ended

May 30, 2019

Derivative Instruments



	Gross Notional Amount		Fair Value of
	Gross Notional Amount		Current Assets⁽¹⁾		Current Liabilities⁽²⁾
As of May 30, 2019
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	190	$	1	$	—

Derivative instruments without hedge accounting designation
Non-designated currency hedges	2,029		2		(12		)

			$	3	$	(12	)

As of August 30, 2018
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	538	$	—	$	(13	)

Derivative instruments without hedge accounting designation
Non-designated currency hedges	1,919		14		(10		)
Convertible notes settlement obligation⁽³⁾			—		(167		)
			14		(177		)

			$	14	$	(190	)


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other for forward contracts and in current debt for convertible notes settlement obligations.


⁽³⁾	The notional amount of convertible notes settlement obligations as of August 30, 2018 was 3 million shares of our common stock.

Derivative Instruments with Hedge Accounting Designation

We utilize currency forward contracts that generally mature within 12 months to hedge our exposure to changes in currency exchange rates. Currency forward contracts are measured at fair value based on market-based observable inputs including currency exchange spot and forward rates, interest rates, and credit-risk spreads (Level 2). We do not use derivative instruments for speculative purposes.

Cash Flow Hedges: We utilize cash flow hedges for our exposure from changes in currency exchange rates for certain capital expenditures. For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gains or losses on derivatives is included as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. For the periods presented prior to the second quarter of 2018, the ineffective and excluded portion of the realized and unrealized gain or loss was included in other non-operating income (expense). As a result of adopting ASU 2017-12, beginning in the second quarter of 2018, the excluded portion of such amounts is included in the same line item in which the underlying transactions affect earnings and the ineffective portion of the realized and unrealized gains or losses on derivatives is included as a component of accumulated other comprehensive income.

We recognized gains of $1 million and losses of $5 million for the third quarter and first nine months of 2019, respectively, and losses of $23 million and $6 million for the third quarter and first nine months of 2018, respectively, in accumulated other comprehensive income from the effective portion of cash flow hedges. Neither the amount excluded from hedge effectiveness nor the reclassifications from accumulated other comprehensive income to earnings were material in the third quarters or first nine months of 2019 or 2018. The amounts from cash flow hedges included in accumulated other comprehensive income that are expected to be reclassified into earnings in the next 12 months were also not material.

Fair Value Hedges: In the second and third quarters of 2018, we utilized fair value hedges for our exposure from changes in currency exchange rates for certain monetary assets and liabilities. For derivative forward contracts designated as fair value hedges, hedge effectiveness was determined by the change in the fair value of the undiscounted spot rate of the forward contract. The changes in fair values of hedge instruments attributed to changes in undiscounted spot rates were recognized in other non-operating income (expense). The time value associated with hedge instruments is excluded from the assessment of the effectiveness of hedges and was recognized on a straight-line basis over the life of hedges to other non-operating income (expense). Amounts recorded to other comprehensive income (loss) for the third quarter and first nine months of 2018 were not material. The effects of fair value hedges on our consolidated statements of operations are included in other non-operating income (expense) and were as follows:



	Quarter ended			Nine months ended
	May 31, 2018			May 31, 2018
Gain (loss) on remeasurement of hedged assets and liabilities	$	28		$	(28	)
Gain (loss) on derivatives designated as hedging instruments	(28		)	28
Amortization of amounts excluded from hedge effectiveness	(13		)	(32		)
	$	(13	)	$	(32	)

Derivative Instruments without Hedge Accounting Designation

Currency Derivatives: We generally utilize a rolling hedge strategy with currency forward contracts that mature within three months to hedge our exposures of monetary assets and liabilities from changes in currency exchange rates. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars and the associated outstanding forward contracts are marked to market. Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2). Realized and unrealized gains and losses on derivative instruments without hedge accounting designation as well as the changes in the underlying monetary assets and liabilities from changes in currency exchange rates are included in other non-operating income (expense). For derivative instruments without hedge accounting designation, we recognized losses of $23 million in the third quarter and first nine months of 2019, and losses of $52 million in the third quarter of 2018, which offset $52 million of gains recognized during the first six months of 2018.

Convertible Notes Settlement Obligations: For settlement obligations associated with our convertible notes subject to mark-to-market accounting treatment, the fair values of the underlying derivative settlement obligations were initially determined using the Black-Scholes option valuation model (Level 2), which requires inputs of stock price, expected stock-price volatility, estimated option life, risk-free interest rate, and dividend rate. The subsequent measurement amounts were based on the volume-weighted-average trading price of our common stock (Level 2). (See "Debt" note.) We recognized gains of $11 million and losses of $55 million in the third quarter and first nine months of 2019, respectively, and losses of $119 million and $143 million for the third quarter and first nine months of 2018, respectively, in other non-operating income (expense), net for the changes in fair value of the derivative settlement obligations.

Equity Plans

9 Months Ended

May 30, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Equity Plans

As of May 30, 2019, 113 million shares of our common stock were available for future awards under our equity plans.

Stock Options

Stock options granted and assumptions used in the Black-Scholes option valuation model were as follows:



	Quarter ended				Nine months ended
	May 30, 2019	May 31, 2018			May 30, 2019			May 31, 2018
Stock options granted	—	—			—			2
Weighted-average grant-date fair value per share	—	$	24.14		$	19.50		$	18.61
Average expected life in years	—	5.4			5.4			5.5
Weighted-average expected volatility	—	45		%	44		%	44		%
Weighted-average risk-free interest rate	—	2.8		%	2.9		%	2.2		%
Expected dividend yield	—	0.0		%	0.0		%	0.0		%

Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")

Restricted Stock Awards activity is summarized as follows:



	Quarter ended				Nine months ended
	May 30, 2019		May 31, 2018		May 30, 2019		May 31, 2018
Restricted stock award shares granted	1		—		7		4
Weighted-average grant-date fair value per share	$	40.00	$	53.77	$	39.83	$	42.14

Employee Stock Purchase Plan ("ESPP")

Our first ESPP offering period ended in January 2019 and we issued 1 million shares to employees at a purchase price per share of $32.50 under the ESPP. Assumptions used in the Black-Scholes option valuation model for the offering period beginning February 2019 were as follows:



Weighted-average grant-date fair value per share	$	10.92
Average expected life in years	0.5
Weighted-average expected volatility	47		%
Weighted-average risk-free interest rate	2.5		%
Expected dividend yield	0.0		%

Stock-based Compensation Expense



	Quarter ended				Nine months ended
	May 30, 2019		May 31, 2018		May 30, 2019		May 31, 2018
Stock-based compensation expense by caption
Cost of goods sold	$	24	$	20	$	73	$	62
Selling, general, and administrative	18		14		55		48
Research and development	16		14		48		41
	$	58	$	48	$	176	$	151

Stock-based compensation expense by type of award
Restricted stock awards	$	44	$	35	$	127	$	107
Stock options	6		13		25		44
Employee Stock Purchase Plan	8		—		24		—
	$	58	$	48	$	176	$	151

Income tax benefits related to share-based payment arrangements were $4 million and $57 million for the third quarter and first nine months of 2019, respectively, and $26 million and $142 million for the third quarter and first nine months of 2018, respectively. Income tax benefits related to share-based compensation for the first quarter of 2018 were offset by an increase in the U.S. valuation allowance. As of May 30, 2019, $385 million of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the third quarter of 2023, resulting in a weighted-average period of 1.3 years.

Revenue and Contract Liabilities

9 Months Ended

May 30, 2019

Revenue from Contract with Customer [Abstract]

Revenue and Contract Liabilities

Our revenues are primarily recognized at a point in time, when control of the promised goods is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Contracts with our customers are generally short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. We estimate a liability for returns using the expected value method based on historical rates of return. In addition, we generally offer price protection to our distributors, which is a form of variable consideration that decreases the transaction price. We estimate the amount of consideration we expect to be entitled to from sales to distributors, using the expected value method, based on historical price adjustments and current pricing trends. Differences between the estimated and actual amounts are recognized as adjustments to revenue. (See "Segment and Other Information" note for disclosure of disaggregated revenue.)

Contract Liabilities



As of	May 30, 2019		Opening Balance as of August 31, 2018
Contract liabilities from customer advances	$	117	$	235
Other contract liabilities	96		113
	$	213	$	348

Our contract liabilities are for advance payments received from customers to secure product in future periods and for other arrangements where we have received amounts in advance of satisfying performance obligations and are reported in the accompanying consolidated balance sheets within other current liabilities and other noncurrent liabilities. Revenue and interest expense associated with contract liabilities for the time value of advance payments was not material in any period presented. As of May 30, 2019, our future performance obligations beyond one year were not material.

Changes in contract liabilities for the first nine months of 2019 were as follows:



Contract liabilities balance as of August 31, 2018	$	348
Revenue recognized from beginning balance	(211		)
Additions and other activity	76
Contract liabilities balance as of May 30, 2019	$	213

Contract liabilities increase as a result of receiving new advance payments from customers and decrease as revenue is recognized from customers purchasing product under advance payment arrangements. Additions and other activity included new customer advances, payments received from license and other arrangements in advance of performance, and interest accrued for financing components on advance payments. Revenue recognized for the first nine months of 2019 from the beginning balance included $183 million from shipments against customer advances and $28 million from meeting other performance obligations.

Consideration Payable to Customers

As of May 30, 2019, other current liabilities included $303 million for estimates of consideration payable to customers, including estimates for pricing adjustments and returns.

Research and Development	9 Months Ended
Research and Development	May 30, 2019
Research and Development [Abstract]
Research and Development	Research and Development We share the cost of certain product and process development activities with development partners. Our R&D expenses were reduced by $6 million and $59 million for the third quarter and first nine months of 2019, respectively, and by $53 million and $167 million for the third quarter and first nine months of 2018, respectively, pursuant to reimbursements under these arrangements. In the second quarter of 2018, we and Intel agreed to independently develop subsequent generations of 3D NAND. Our 3D NAND joint development agreement with Intel was substantially completed in the third quarter of 2019. In the fourth quarter of 2018, we announced that we and Intel will no longer jointly develop 3D XPoint technology beyond the second generation. We expect development of the second generation of 3D XPoint technology to be substantially completed in the first quarter of 2020.

Other Operating (Income) Expense, Net

9 Months Ended

May 30, 2019

Other Income and Expenses [Abstract]

Other Operating (Income) Expense, Net



	Quarter ended						Nine months ended
	May 30, 2019			May 31, 2018			May 30, 2019		May 31, 2018
Restructure and asset impairments	$	9		$	8		$	93	$	21
Other	(3		)	(52		)	46		(70		)
	$	6		$	(44	)	$	139	$	(49	)

Restructure and asset impairments primarily relate to our continued emphasis to centralize certain key functions. As of May 30, 2019 and August 30, 2018, other current liabilities included $23 million and $12 million, respectively, for such restructure activities. Subsequent to the end of the third quarter of 2019, we finalized the sale of our 200mm fabrication facility in Singapore and expect to recognize a gain of approximately $120 million in the fourth quarter of 2019.

Other Non-Operating Income (Expense), Net

9 Months Ended

May 30, 2019

Other Nonoperating Income (Expense) [Abstract]

Other Non-Operating Income (Expense), Net



	Quarter ended						Nine months ended
	May 30, 2019			May 31, 2018			May 30, 2019			May 31, 2018
Loss on debt prepayments, repurchases, and conversions	$	(317	)	$	(168	)	$	(386	)	$	(386	)
Loss from changes in currency exchange rates	(1		)	(24		)	(9		)	(60		)
Other	1			(1		)	3			(4		)
	$	(317	)	$	(193	)	$	(392	)	$	(450	)

Income Taxes

9 Months Ended

May 30, 2019

Income Tax Disclosure [Abstract]

Income Taxes

On December 22, 2017, the United States enacted comprehensive tax legislation, commonly referred to as the Tax Cuts and Jobs Act (the "Tax Act"), which imposed a one-time transition tax in 2018 (the "Repatriation Tax") and, beginning in 2019, created a new minimum tax on certain foreign earnings (the "Foreign Minimum Tax"). SEC Staff Accounting Bulletin No. 118 ("SAB 118") allows the use of provisional amounts (reasonable estimates) if the analyses of the impacts of the Tax Act have not been completed when financial statements are issued. During the first quarter of 2019, we finalized the computations of the income tax effects of the Tax Act. As such, in accordance with SAB 118, our accounting for the effects of the Tax Act is complete.

Our income tax (provision) benefit consisted of the following:



	Quarter ended						Nine months ended
	May 30, 2019			May 31, 2018			May 30, 2019			May 31, 2018
Income tax (provision) benefit, excluding items below	$	125		$	(78	)	$	(469	)	$	(161	)
Utilization of and other changes in net deferred tax assets of MMJ, MMT, and MTTW	(32		)	(35		)	(162		)	(78		)
Repatriation Tax, net of adjustments related to uncertain tax positions	42			222			9			(1,113		)
Release of the valuation allowance on net deferred tax assets of our U.S. operations	—			—			—			1,337
Remeasurement of deferred tax assets and liabilities reflecting lower U.S. corporate tax rates	—			—			—			(133		)
	$	135		$	109		$	(622	)	$	(148	)

Our income tax benefit in the third quarter of 2019 was primarily due to reductions in our effective tax rate, profit before tax, and the Foreign Minimum Tax. In addition, in the third quarter of 2019, we recorded tax benefits related to our deferred tax liabilities on unremitted earnings due to Tax Act-related law changes made effective during the third quarter.

As of May 30, 2019, gross unrecognized income tax benefits were $390 million, substantially all of which would affect our effective tax rate in the future, if recognized. The amount accrued for interest and penalties related to uncertain tax positions was not material for any period presented.

We operate in a number of tax jurisdictions outside the United States, including Singapore, where we have tax incentive arrangements, which expire in whole or in part at various dates through 2034, that are conditional, in part, upon meeting certain business operations and employment thresholds. The effect of tax incentive arrangements reduced our tax provision by $71 million (benefiting our diluted earnings per share by $0.06) and $742 million ($0.65 per diluted share) for the third quarter and first nine months of 2019, respectively, and by $527 million ($0.43 per diluted share) and $1.35 billion ($1.10 per diluted share) for the third quarter and first nine months of 2018, respectively.

Earnings Per Share

9 Months Ended

May 30, 2019

Earnings Per Share [Abstract]

Earnings Per Share



	Quarter ended					Nine months ended
	May 30, 2019			May 31, 2018		May 30, 2019			May 31, 2018
Net income attributable to Micron – Basic	$	840		$	3,823	$	5,752		$	9,810
Assumed conversion of debt	(4		)	—		(6		)	—
Net income attributable to Micron – Diluted	$	836		$	3,823	$	5,746		$	9,810

Weighted-average common shares outstanding – Basic	1,105			1,159		1,117			1,150
Dilutive effect of equity plans and convertible notes	24			76		31			83
Weighted-average common shares outstanding – Diluted	1,129			1,235		1,148			1,233

Earnings per share
Basic	$	0.76		$	3.30	$	5.15		$	8.53
Diluted	0.74			3.10		5.01			7.96

Antidilutive potential common stock shares that could dilute basic earnings per share in the future were 6 million and 7 million for the third quarter and first nine months of 2019, respectively, and 2 million and 3 million for the third quarter and first nine months of 2018, respectively.

Segment and Other Information

9 Months Ended

May 30, 2019

Segment Reporting [Abstract]

Segment and Other Information

Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision maker. We have the following four business units, which are our reportable segments:

Compute and Networking Business Unit ("CNBU"): Includes memory products sold into data center, client, graphics, and networking markets.

Mobile Business Unit ("MBU"): Includes memory products sold into smartphone and other mobile-device markets.

Storage Business Unit ("SBU"): Includes SSDs and other storage products, including component-level solutions, sold into data center, client, and consumer SSD markets, other discrete storage products sold in component and wafer forms to the removable storage markets, and sales of 3D XPoint memory.

Embedded Business Unit ("EBU"): Includes memory and storage products sold into automotive, industrial, and consumer markets.

Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.



	Quarter ended						Nine months ended
	May 30, 2019			May 31, 2018			May 30, 2019			May 31, 2018
Revenue
CNBU	$	2,079		$	3,988		$	8,065		$	10,891
MBU	1,174			1,753			4,997			4,684
SBU	813			1,143			2,978			3,780
EBU	700			897			2,432			2,556
All Other	22			16			64			40
	$	4,788		$	7,797		$	18,536		$	21,951

Operating income (loss)
CNBU	$	800		$	2,615		$	4,171		$	6,858
MBU	331			860			2,241			2,054
SBU	(198		)	156			(138		)	807
EBU	173			386			822			1,091
All Other	4			—			11			(6		)
	1,110			4,017			7,107			10,804

Unallocated
Stock-based compensation	(58		)	(48		)	(176		)	(151		)
Start-up and preproduction costs	(23		)	—			(46		)	—
Employee severance	—			—			(37		)	—
Restructure and asset impairments	(9		)	(8		)	(90		)	(21		)
Other	(10		)	(8		)	(32		)	(15		)
	(100		)	(64		)	(381		)	(187		)

Operating income	$	1,010		$	3,953		$	6,726		$	10,617

Revenue by product type was as follows:



	Quarter ended				Nine months ended
	May 30, 2019		May 31, 2018		May 30, 2019		May 31, 2018
DRAM	$	3,041	$	5,541	$	12,174	$	15,316
NAND	1,461		1,949		5,416		5,660
Other (primarily 3D XPoint memory and NOR)	286		307		946		975
	$	4,788	$	7,797	$	18,536	$	21,951

Customer Concentrations: Revenue from Huawei was 13% of total revenue for the first nine months of 2019.

Basis of Presentation (Policies)	9 Months Ended
Basis of Presentation (Policies)	May 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting	The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 30, 2018, except for changes related to recently adopted accounting standards. See "Recently Adopted Accounting Standards" note. Prior year information is presented in accordance with the accounting guidance in effect during that period and has not been recast for recently adopted accounting standards. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to fairly state the financial information set forth herein.
Comparability	Prior year information is presented in accordance with the accounting guidance in effect during that period and has not been recast for recently adopted accounting standards.
Reclassifications	Certain reclassifications have been made to prior period amounts to conform to current period presentation.
Fiscal Period	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2019 and 2018 each contain 52 weeks.

Variable Interest Entities (Policies)	9 Months Ended
Variable Interest Entities (Policies)	May 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments.

Recently Adopted Accounting Standards (Tables)

9 Months Ended

May 30, 2019

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Financial Statement Impact from Adoption of New Accounting Standards



	Quarter ended May 30, 2019									Nine months ended May 30, 2019
	As Reported			Adjustments			Amounts Without the Effects of Adoption of ASC 606			As Reported			Adjustments			Amounts Without the Effects of Adoption of ASC 606
Revenue	$	4,788		$	43		$	4,831		$	18,536		$	(72	)	$	18,464
Cost of goods sold	2,960			4			2,964			9,229			(65		)	9,164
Interest expense	(29		)	2			(27		)	(89		)	5			(84		)
Income tax (provision) benefit	135			(8		)	127			(622		)	(13		)	(635		)
Net income attributable to Micron	840			33			873			5,752			(15		)	5,737



As of May 30, 2019	As Reported		Adjustments			Amounts Without the Effects of Adoption of ASC 606
Receivables	$	3,257	$	(112	)	$	3,145
Other current assets	215		(41		)	174
Deferred tax assets	817		82			899
Accounts payable and accrued expenses	3,494		3			3,497
Other current liabilities	557		(8		)	549
Other noncurrent liabilities	417		(1		)	416
Retained earnings	30,201		(65		)	30,136

The following table summarizes the effects of adopting ASU 2016-16 and ASC 606:




	Ending Balance as of August 30, 2018		ASU 2016-16			ASC 606			Opening Balance as of August 31, 2018
Receivables	$	5,478	$	—		$	114		$	5,592
Inventories	3,595		—			(5		)	3,590
Other current assets	164		(14		)	30			180
Deferred tax assets	1,022		56			(92		)	986
Other current liabilities	521		—			(4		)	517
Other noncurrent liabilities	354		—			1			355
Retained earnings	24,395		42			50			24,487

Cash and Investments (Tables)

9 Months Ended

May 30, 2019

Investments [Abstract]

Cash and Investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	May 30, 2019								August 30, 2018
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	3,171	$	—	$	—	$	3,171	$	3,223	$	—	$	—	$	3,223
Level 1⁽²⁾
Money market funds	1,208		—		—		1,208		2,443		—		—		2,443
Level 2⁽³⁾
Certificates of deposit	732		749		5		1,486		806		11		2		819
Corporate bonds	—		516		704		1,220		3		172		272		447
Government securities	11		131		200		342		5		63		103		171
Asset-backed securities	—		83		258		341		—		34		96		130
Commercial paper	35		53		—		88		26		16		—		42
	5,157		$	1,532	$	1,167	$	7,856	6,506		$	296	$	473	$	7,275
Restricted cash⁽⁴⁾	77								81
Cash, cash equivalents, and restricted cash	$	5,234							$	6,587


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾


⁽⁴⁾	Restricted cash is included in other noncurrent assets and primarily consisted of balances related to the MMJ Creditor Payments. The restrictions on the MMJ Creditor Payments lapse upon approval by the trustees and/or Tokyo District Court.

Cash and equivalents and the fair values of available-for-sale investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	May 30, 2019								August 30, 2018
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	3,171	$	—	$	—	$	3,171	$	3,223	$	—	$	—	$	3,223
Level 1⁽²⁾
Money market funds	1,208		—		—		1,208		2,443		—		—		2,443
Level 2⁽³⁾
Certificates of deposit	732		749		5		1,486		806		11		2		819
Corporate bonds	—		516		704		1,220		3		172		272		447
Government securities	11		131		200		342		5		63		103		171
Asset-backed securities	—		83		258		341		—		34		96		130
Commercial paper	35		53		—		88		26		16		—		42
	5,157		$	1,532	$	1,167	$	7,856	6,506		$	296	$	473	$	7,275
Restricted cash⁽⁴⁾	77								81
Cash, cash equivalents, and restricted cash	$	5,234							$	6,587


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾


⁽⁴⁾	Restricted cash is included in other noncurrent assets and primarily consisted of balances related to the MMJ Creditor Payments. The restrictions on the MMJ Creditor Payments lapse upon approval by the trustees and/or Tokyo District Court.

Receivables (Tables)

9 Months Ended

May 30, 2019

Receivables [Abstract]

Schedule of Receivables



As of	May 30, 2019		August 30, 2018
Trade receivables	$	2,848	$	5,056
Income and other taxes	202		161
Other	207		261
	$	3,257	$	5,478

Inventories (Tables)

9 Months Ended

May 30, 2019

Inventory Disclosure [Abstract]

Schedule of Inventories



As of	May 30, 2019		August 30, 2018
Finished goods	$	853	$	815
Work in process	3,537		2,357
Raw materials and supplies	515		423
	$	4,905	$	3,595

Property, Plant, and Equipment (Tables)

9 Months Ended

May 30, 2019

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant, and Equipment



As of	May 30, 2019			August 30, 2018
Land	$	352		$	345
Buildings	10,167			8,680
Equipment⁽¹⁾	42,626			38,249
Construction in progress⁽²⁾	1,893			1,162
Software	767			655
	55,805			49,091
Accumulated depreciation	(28,667		)	(25,419		)
	$	27,138		$	23,672


⁽¹⁾	Included costs related to equipment not placed into service of $2.24 billion and $1.73 billion, as of May 30, 2019 and August 30, 2018, respectively.


⁽²⁾	Included building-related construction, tool installation, and software costs for assets not yet placed into service.

Intangible Assets and Goodwill (Tables)

9 Months Ended

May 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets and Goodwill



As of	May 30, 2019					August 30, 2018
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Amortizing assets
Product and process technology	$	574	$	(235	)	$	567	$	(344	)
Non-amortizing assets
In-process R&D	—		—			108		—

Total intangible assets	$	574	$	(235	)	$	675	$	(344	)

Goodwill	$	1,228				$	1,228

Accounts Payable and Accrued Expenses (Tables)

9 Months Ended

May 30, 2019

Payables and Accruals [Abstract]

Schedule of Accounts Payable And Accrued Expenses



As of	May 30, 2019		August 30, 2018
Accounts payable	$	1,336	$	1,692
Property, plant, and equipment payables	1,160		1,238
Salaries, wages, and benefits	565		841
Income and other taxes	254		402
Other	179		201
	$	3,494	$	4,374

Debt (Tables)

9 Months Ended

May 30, 2019

Debt Disclosure [Abstract]

Schedule of Debt



As of	May 30, 2019										August 30, 2018
					Net Carrying Amount						Net Carrying Amount
Instrument	Stated Rate		Effective Rate		Current		Long-Term		Total		Current		Long-Term		Total
IMFT Member Debt⁽¹⁾	N/A		N/A		$	858	$	—	$	858	$	—	$	1,009	$	1,009
Capital lease obligations	N/A		4.20	%	233		415		648		310		536		846
MMJ Creditor Payments	N/A		9.76	%	187		—		187		309		183		492
2022 Term Loan B	4.24	%	4.65	%	5		716		721		5		720		725
2024 Notes	4.64	%	4.76	%	—		597		597		—		—		—
2025 Notes	5.50	%	5.56	%	—		516		516		—		515		515
2026 Notes	4.98	%	5.07	%	—		497		497		—		—		—
2029 Notes	5.33	%	5.40	%	—		696		696		—		—		—
2032D Notes	3.13	%	6.33	%	—		126		126		—		132		132
2033F Notes	2.13	%	4.93	%	63		—		63		235		—		235
2043G Notes	3.00	%	6.76	%	—		—		—		—		682		682
					$	1,346	$	3,563	$	4,909	$	859	$	3,777	$	4,636


⁽¹⁾	IMFT Member Debt was classified as current as of May 30, 2019 as a result of exercising our option to acquire Intel's interest in IMFT.

Schedule of Debt Conversions, Settlements, and Issuances

The following table presents the effects of conversions, settlements, and issuance of debt in the first nine months of 2019:



Nine months ended May 30, 2019	Increase (Decrease) in Principal			Increase (Decrease) in Carrying Value			Increase (Decrease) in Cash			Decrease in Equity			Gain (Loss)
Settled conversions
2032D Notes	$	(10	)	$	(9	)	$	(35	)	$	(28	)	$	2
2033F Notes	(43		)	(173		)	(184		)	(23		)	12
2043G Notes	(1,019		)	(691		)	(1,426		)	(326		)	(400		)
Issuances
2024 Notes	600			597			597			—			—
2026 Notes	500			497			497			—			—
2029 Notes	700			695			695			—			—
	$	728		$	916		$	144		$	(377	)	$	(386	)

Variable Interest Entity [Line Items]

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Equity (Tables)

9 Months Ended

May 30, 2019

Schedule Of Noncontrolling Interests In Subsidiaries



As of	May 30, 2019				August 30, 2018
	Balance		Percentage		Balance		Percentage
IMFT	$	867	49	%	$	853	49	%
Other	—		—		17		Various
	$	867			$	870

Variable Interest Entity [Line Items]

Total IMFT assets and liabilities

The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:



As of	May 30, 2019		August 30, 2018
Assets
Cash and equivalents	$	184	$	91
Receivables	125		126
Inventories	122		114
Other current assets	5		8
Total current assets	436		339
Property, plant, and equipment	2,352		2,641
Other noncurrent assets	37		45
Total assets	$	2,825	$	3,025

Liabilities
Accounts payable and accrued expenses	$	106	$	138
Current debt	865		20
Other current liabilities	41		9
Total current liabilities	1,012		167
Long-term debt	54		1,064
Other noncurrent liabilities	23		74
Total liabilities	$	1,089	$	1,305

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Estimated fair value and carrying value of debt instruments

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details

Fair Value Measurements (Tables)

9 Months Ended

May 30, 2019

Fair Value Disclosures [Abstract]



As of	May 30, 2019				August 30, 2018
	Fair Value		Carrying Value		Fair Value		Carrying Value
Notes and MMJ Creditor Payments	$	4,165	$	4,072	$	2,798	$	2,741
Convertible notes	643		189		3,124		1,049

Derivative Instruments (Tables)

9 Months Ended

May 30, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments



	Gross Notional Amount		Fair Value of
	Gross Notional Amount		Current Assets⁽¹⁾		Current Liabilities⁽²⁾
As of May 30, 2019
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	190	$	1	$	—

Derivative instruments without hedge accounting designation
Non-designated currency hedges	2,029		2		(12		)

			$	3	$	(12	)

As of August 30, 2018
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	538	$	—	$	(13	)

Derivative instruments without hedge accounting designation
Non-designated currency hedges	1,919		14		(10		)
Convertible notes settlement obligation⁽³⁾			—		(167		)
			14		(177		)

			$	14	$	(190	)


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other for forward contracts and in current debt for convertible notes settlement obligations.


⁽³⁾	The notional amount of convertible notes settlement obligations as of August 30, 2018 was 3 million shares of our common stock.

Schedule of Gains and Losses on Fair Value Hedges



	Quarter ended			Nine months ended
	May 31, 2018			May 31, 2018
Gain (loss) on remeasurement of hedged assets and liabilities	$	28		$	(28	)
Gain (loss) on derivatives designated as hedging instruments	(28		)	28
Amortization of amounts excluded from hedge effectiveness	(13		)	(32		)
	$	(13	)	$	(32	)

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959

+ Details

Equity Plans (Tables)

9 Months Ended

May 30, 2019

Stock Options Granted and Valuation Assumptions



	Quarter ended				Nine months ended
	May 30, 2019	May 31, 2018			May 30, 2019			May 31, 2018
Stock options granted	—	—			—			2
Weighted-average grant-date fair value per share	—	$	24.14		$	19.50		$	18.61
Average expected life in years	—	5.4			5.4			5.5
Weighted-average expected volatility	—	45		%	44		%	44		%
Weighted-average risk-free interest rate	—	2.8		%	2.9		%	2.2		%
Expected dividend yield	—	0.0		%	0.0		%	0.0		%

Schedule of Restricted Stock Awards Activity



	Quarter ended				Nine months ended
	May 30, 2019		May 31, 2018		May 30, 2019		May 31, 2018
Restricted stock award shares granted	1		—		7		4
Weighted-average grant-date fair value per share	$	40.00	$	53.77	$	39.83	$	42.14

Employee Stock Purchase Plan Valuation Assumptions



Weighted-average grant-date fair value per share	$	10.92
Average expected life in years	0.5
Weighted-average expected volatility	47		%
Weighted-average risk-free interest rate	2.5		%
Expected dividend yield	0.0		%

Stock-based Compensation Expense by Caption



	Quarter ended				Nine months ended
	May 30, 2019		May 31, 2018		May 30, 2019		May 31, 2018
Stock-based compensation expense by caption
Cost of goods sold	$	24	$	20	$	73	$	62
Selling, general, and administrative	18		14		55		48
Research and development	16		14		48		41
	$	58	$	48	$	176	$	151

Stock-based compensation expense by type of award
Restricted stock awards	$	44	$	35	$	127	$	107
Stock options	6		13		25		44
Employee Stock Purchase Plan	8		—		24		—
	$	58	$	48	$	176	$	151

Revenue (Tables)

9 Months Ended

May 30, 2019

Revenue from Contract with Customer [Abstract]

Contract Liabilities

Changes in contract liabilities for the first nine months of 2019 were as follows:



Contract liabilities balance as of August 31, 2018	$	348
Revenue recognized from beginning balance	(211		)
Additions and other activity	76
Contract liabilities balance as of May 30, 2019	$	213



As of	May 30, 2019		Opening Balance as of August 31, 2018
Contract liabilities from customer advances	$	117	$	235
Other contract liabilities	96		113
	$	213	$	348

Other Operating (Income) Expense, Net (Tables)

9 Months Ended

May 30, 2019

Other Income and Expenses [Abstract]

Schedule of Other Operating (Income) Expense, Net



	Quarter ended						Nine months ended
	May 30, 2019			May 31, 2018			May 30, 2019		May 31, 2018
Restructure and asset impairments	$	9		$	8		$	93	$	21
Other	(3		)	(52		)	46		(70		)
	$	6		$	(44	)	$	139	$	(49	)

Other Non-Operating Income (Expense), Net (Tables)

9 Months Ended

May 30, 2019

Other Nonoperating Income (Expense) [Abstract]

Schedule of Other Nonoperating Income (Expense), Net



	Quarter ended						Nine months ended
	May 30, 2019			May 31, 2018			May 30, 2019			May 31, 2018
Loss on debt prepayments, repurchases, and conversions	$	(317	)	$	(168	)	$	(386	)	$	(386	)
Loss from changes in currency exchange rates	(1		)	(24		)	(9		)	(60		)
Other	1			(1		)	3			(4		)
	$	(317	)	$	(193	)	$	(392	)	$	(450	)

Income Taxes (Tables)

9 Months Ended

May 30, 2019

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax (Provision) Benefit

Our income tax (provision) benefit consisted of the following:



	Quarter ended						Nine months ended
	May 30, 2019			May 31, 2018			May 30, 2019			May 31, 2018
Income tax (provision) benefit, excluding items below	$	125		$	(78	)	$	(469	)	$	(161	)
Utilization of and other changes in net deferred tax assets of MMJ, MMT, and MTTW	(32		)	(35		)	(162		)	(78		)
Repatriation Tax, net of adjustments related to uncertain tax positions	42			222			9			(1,113		)
Release of the valuation allowance on net deferred tax assets of our U.S. operations	—			—			—			1,337
Remeasurement of deferred tax assets and liabilities reflecting lower U.S. corporate tax rates	—			—			—			(133		)
	$	135		$	109		$	(622	)	$	(148	)

Earnings Per Share (Tables)

9 Months Ended

May 30, 2019

Earnings Per Share [Abstract]

Basic and Diluted Earnings Per Share



	Quarter ended					Nine months ended
	May 30, 2019			May 31, 2018		May 30, 2019			May 31, 2018
Net income attributable to Micron – Basic	$	840		$	3,823	$	5,752		$	9,810
Assumed conversion of debt	(4		)	—		(6		)	—
Net income attributable to Micron – Diluted	$	836		$	3,823	$	5,746		$	9,810

Weighted-average common shares outstanding – Basic	1,105			1,159		1,117			1,150
Dilutive effect of equity plans and convertible notes	24			76		31			83
Weighted-average common shares outstanding – Diluted	1,129			1,235		1,148			1,233

Earnings per share
Basic	$	0.76		$	3.30	$	5.15		$	8.53
Diluted	0.74			3.10		5.01			7.96

Segment and Other Information (Tables)

9 Months Ended

May 30, 2019

Segment Reporting [Abstract]

Schedule of Results by Segment



	Quarter ended						Nine months ended
	May 30, 2019			May 31, 2018			May 30, 2019			May 31, 2018
Revenue
CNBU	$	2,079		$	3,988		$	8,065		$	10,891
MBU	1,174			1,753			4,997			4,684
SBU	813			1,143			2,978			3,780
EBU	700			897			2,432			2,556
All Other	22			16			64			40
	$	4,788		$	7,797		$	18,536		$	21,951

Operating income (loss)
CNBU	$	800		$	2,615		$	4,171		$	6,858
MBU	331			860			2,241			2,054
SBU	(198		)	156			(138		)	807
EBU	173			386			822			1,091
All Other	4			—			11			(6		)
	1,110			4,017			7,107			10,804

Unallocated
Stock-based compensation	(58		)	(48		)	(176		)	(151		)
Start-up and preproduction costs	(23		)	—			(46		)	—
Employee severance	—			—			(37		)	—
Restructure and asset impairments	(9		)	(8		)	(90		)	(21		)
Other	(10		)	(8		)	(32		)	(15		)
	(100		)	(64		)	(381		)	(187		)

Operating income	$	1,010		$	3,953		$	6,726		$	10,617

Revenue by Product Type

Revenue by product type was as follows:



	Quarter ended				Nine months ended
	May 30, 2019		May 31, 2018		May 30, 2019		May 31, 2018
DRAM	$	3,041	$	5,541	$	12,174	$	15,316
NAND	1,461		1,949		5,416		5,660
Other (primarily 3D XPoint memory and NOR)	286		307		946		975
	$	4,788	$	7,797	$	18,536	$	21,951

Variable Interest Entities (Details) - USD ($) $ in Millions	May 30, 2019	Aug. 30, 2018
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets and Liabilities, Net [Abstract]
Variable Interest Entity (PTI Xi'an), Nonconsolidated, Carrying Amount of Capital Leases	$ 51	$ 63
Variable Interest Entity (PTI Xi'an), Nonconsolidated, Carrying Amount of PP&E	$ 53	$ 63

Recently Adopted Accounting Standards (Details) - USD ($) $ in Millions	May 30, 2019	Aug. 31, 2018	Aug. 30, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Receivables	$ 3,257	$ 5,592	$ 5,478
Inventories	4,905	3,590	3,595
Other current assets	215	180	164
Deferred tax assets	817	986	1,022
Other current liabilities	557	517	521
Other noncurrent liabilities	417	355	354
Retained earnings	$ 30,201	24,487	$ 24,395
ASC 606
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Receivables		114
Inventories		(5)
Other current assets		30
Deferred tax assets		(92)
Other current liabilities		(4)
Other noncurrent liabilities		1
Retained earnings		50
ASU 2016-16
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Receivables		0
Inventories		0
Other current assets		(14)
Deferred tax assets		56
Other current liabilities		0
Other noncurrent liabilities		0
Retained earnings		$ 42

Recently Adopted Accounting Standards Revenue Initial Application Period Cumulative Effect (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 30, 2019	May 31, 2018	May 30, 2019	May 31, 2018	Aug. 31, 2018	Aug. 30, 2018
Income Statement [Abstract]
Revenue	$ 4,788	$ 7,797	$ 18,536	$ 21,951
Cost of goods sold	2,960	3,074	9,229	9,211
Interest expense	(29)	(80)	(89)	(292)
Income tax (provision) benefit	135	109	(622)	(148)
Net income attributable to Micron	840	$ 3,823	5,752	$ 9,810
Balance Sheet [Abstract]
Receivables	3,257		3,257		$ 5,592	$ 5,478
Other current assets	215		215		180	164
Deferred tax assets	817		817		986	1,022
Accounts payable and accrued expenses	3,494		3,494			4,374
Other current liabilities	557		557		517	521
Other noncurrent liabilities	417		417		355	354
Retained earnings	30,201		30,201		24,487	$ 24,395
ASC 606
Balance Sheet [Abstract]
Receivables					114
Other current assets					30
Deferred tax assets					(92)
Other current liabilities					(4)
Other noncurrent liabilities					1
Retained earnings					$ 50
Difference between Revenue Guidance in Effect before and after Topic 606 \| ASC 606
Income Statement [Abstract]
Revenue	(43)		72
Cost of goods sold	(4)		65
Interest expense	(2)		(5)
Income tax (provision) benefit	8		13
Net income attributable to Micron	(33)		15
Balance Sheet [Abstract]
Receivables	112		112
Other current assets	41		41
Deferred tax assets	(82)		(82)
Accounts payable and accrued expenses	(3)		(3)
Other current liabilities	8		8
Other noncurrent liabilities	1		1
Retained earnings	65		65
Calculated under Revenue Guidance in Effect before Topic 606 \| ASC 606
Income Statement [Abstract]
Revenue	4,831		18,464
Cost of goods sold	2,964		9,164
Interest expense	(27)		(84)
Income tax (provision) benefit	127		(635)
Net income attributable to Micron	873		5,737
Balance Sheet [Abstract]
Receivables	3,145		3,145
Other current assets	174		174
Deferred tax assets	899		899
Accounts payable and accrued expenses	3,497		3,497
Other current liabilities	549		549
Other noncurrent liabilities	416		416
Retained earnings	$ 30,136		$ 30,136

Cash and Investments (Details) - USD ($)
$ in Millions

9 Months Ended

May 30, 2019

Aug. 30, 2018

May 31, 2018

Aug. 31, 2017

Debt Securities, Available-for-sale [Line Items]

$ 5,157

$ 6,506

1,532

296

^[1]

1,167

473

Cash, cash equivalents, and restricted cash

7,856

7,275

Restricted cash

^[2]

5,234

6,587

$ 6,927

$ 5,216

Debt Securities, Available-for-sale, Unrealized Loss Position [Abstract]

Available-for-sale securities in an unrealized loss position for longer than twelve months

$ 0

Minimum

Debt Securities, Available-for-sale [Line Items]

Long-term marketable investments, general maturities (in years)

1 year

Maximum

Debt Securities, Available-for-sale [Line Items]

Long-term marketable investments, general maturities (in years)

4 years

Cash

Debt Securities, Available-for-sale [Line Items]

$ 3,171

3,223

Money market funds | Level 1

3,171

3,223

Debt Securities, Available-for-sale [Line Items]

^[3]

1,208

2,443

^[3]

^[1],[3]

Certificates of deposit | Level 2

^[3]

1,208

2,443

Debt Securities, Available-for-sale [Line Items]

^[4]

732

806

^[4]

749

^[1],[4]

Corporate Bonds | Level 2

^[4]

1,486

819

Debt Securities, Available-for-sale [Line Items]

^[4]

^[4]

516

172

^[1],[4]

704

272

Government securities | Level 2

^[4]

1,220

447

Debt Securities, Available-for-sale [Line Items]

^[4]

^[4]

131

^[1],[4]

200

103

Asset-backed securities | Level 2

^[4]

342

171

Debt Securities, Available-for-sale [Line Items]

^[4]

^[4]

^[1],[4]

258

Commercial paper | Level 2

^[4]

341

130

Debt Securities, Available-for-sale [Line Items]

^[4]

^[4]

^[1],[4]

Property, Plant and Equipment, Net, by Type [Abstract]

^[4]

$ 88

$ 42

[1]	The maturities of long-term marketable securities range from one to four years.
[2]	Restricted cash is included in other noncurrent assets and primarily consisted of balances related to the MMJ Creditor Payments. The restrictions on the MMJ Creditor Payments lapse upon approval by the trustees and/or Tokyo District Court.
[3]	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.
[4]	The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analyses to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of May 30, 2019 or August 30, 2018.

Receivables (Details) - USD ($) $ in Millions	May 30, 2019	Aug. 31, 2018	Aug. 30, 2018
Receivables [Abstract]
Trade receivables	$ 2,848		$ 5,056
Income and other taxes	202		161
Other	207		261
Receivables	$ 3,257	$ 5,592	$ 5,478

Inventories (Details) - USD ($) $ in Millions	May 30, 2019	Aug. 31, 2018	Aug. 30, 2018
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Finished goods	$ 853		$ 815
Work in process	3,537		2,357
Raw materials and supplies	515		423
Inventories	$ 4,905	$ 3,590	$ 3,595

Property, Plant, and Equipment (Details) - USD ($)
$ in Millions

May 30, 2019

Aug. 30, 2018

Property, plant, and equipment, net

$ 55,805

$ 49,091

Accumulated depreciation

(28,667)

(25,419)

27,138

23,672

Land

Property, Plant and Equipment, Net, by Type [Abstract]

Property, Plant and Equipment, Net, by Type [Abstract]

352

345

Buildings

Property, Plant and Equipment, Net, by Type [Abstract]

10,167

8,680

Equipment

Equipment not placed into service

^[1]

42,626

38,249

Property, Plant and Equipment, Net, by Type [Abstract]

Property, Plant and Equipment, Net, by Type [Abstract]

2,240

1,730

Construction in progress

Property, Plant and Equipment, Net, by Type [Abstract]

^[2]

1,893

1,162

Software

Long-term Debt, by Current and Noncurrent [Abstract]

$ 767

$ 655

[1]	Included costs related to equipment not placed into service of $2.24 billion and $1.73 billion, as of May 30, 2019 and August 30, 2018, respectively.
[2]	Included building-related construction, tool installation, and software costs for assets not yet placed into service.

Intangible Assets and Goodwill - Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Nov. 29, 2018	May 30, 2019	May 31, 2018	Aug. 30, 2018
Amortizing assets [Line Items]
Gross Amount, Product and process technology		$ 574		$ 567
Accumulated Amortization, Product and process technology		(235)		(344)
Annual amortization expense for intangible assets [Abstract]
Remainder of 2019		18
2020		68
2021		59
2022		48
2023		43
Non-amortizing assets [Line Items]
Gross Amount, In-process R&D		0		108
Intangible Assets, Net (Including Goodwill) [Abstract]
Gross Amount, Total intangible assets (excluding Goodwill)		574		675
Goodwill		1,228		$ 1,228
Product and process technology
Amortizing assets [Line Items]
Increase in amortizing assets		$ 71	$ 27
In-process R&D placed in service
Amortizing assets [Line Items]
Increase in amortizing assets	$ 108
Useful life assigned to assets placed in service		6 years
Weighted Average \| Product and process technology
Amortizing assets [Line Items]
Useful life assigned to assets placed in service		8 years	11 years

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	May 30, 2019	Aug. 30, 2018
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accounts payable	$ 1,336	$ 1,692
Property, plant, and equipment payables	1,160	1,238
Salaries, wages, and benefits	565	841
Income and other taxes	254	402
Other	179	201
Total accounts payable and accrued expenses	$ 3,494	$ 4,374

Debt - Schedule of Long-term Debt (Details)

9 Months Ended

May 30, 2019

USD ($)

Feb. 06, 2019

USD ($)

Aug. 30, 2018

USD ($)

$ 1,346,000,000

$ 859,000,000

3,563,000,000

3,777,000,000

Conversion rights, minimum number of trading days (in days) | d

$ 4,909,000,000

4,636,000,000

Convertible Debt

Convertible Senior Notes

Conversion rights, consecutive trading period (in days) | d

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Conversion value of convertible notes

$ 641,000,000

Principal amount of convertible notes

198,000,000

Conversion value in excess of principal

443,000,000

Convertible Debt | IMFT Member Debt

Long-term Debt, by Current and Noncurrent [Abstract]

858,000,000

^[1]

^[1]

1,009,000,000

Convertible Debt | 2032D Notes

$ 858,000,000

^[1]

1,009,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

3.13%

6.33%

$ 0

126,000,000

132,000,000

Convertible Debt | 2033F Notes

$ 126,000,000

132,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

2.13%

4.93%

$ 63,000,000

235,000,000

Convertible Debt | 2043G Notes

$ 63,000,000

235,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

3.00%

6.76%

$ 0

682,000,000

Capital lease obligations

682,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

233,000,000

310,000,000

415,000,000

536,000,000

Reorganization obligation

$ 648,000,000

846,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

9.76%

$ 187,000,000

309,000,000

183,000,000

Secured Debt | 2022 Term Loan B

$ 187,000,000

492,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

4.24%

4.65%

$ 5,000,000

5,000,000

716,000,000

720,000,000

Corporate Bonds | 2025 Notes

$ 721,000,000

725,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

5.50%

5.56%

$ 0

516,000,000

515,000,000

Corporate Bonds | 2024 Notes, 2026 Notes, and 2029 Notes

$ 516,000,000

515,000,000

Senior Unsecured Notes

Debt issuance costs

$ 11,000,000

Restricted subsidiaries, ownership percentage by parent

80.00%

Redemption price percentage upon change in control

101.00%

Corporate Bonds | 2024 Notes

Long-term Debt, by Current and Noncurrent [Abstract]

4.64%

4.76%

$ 0

597,000,000

Corporate Bonds | 2026 Notes

$ 597,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

4.98%

5.07%

$ 0

497,000,000

Corporate Bonds | 2029 Notes

$ 497,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

5.33%

5.40%

$ 0

696,000,000

Notes Payable, Other Payables | Revolving Credit Facility

696,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

Available Revolving Credit Facility [Abstract]

Line of credit facility, Maximum borrowing capacity

$ 2,500,000,000

$ 2,000,000,000

Weighted Average | Capital lease obligations

Long-term Debt, by Current and Noncurrent [Abstract]

Minimum | Corporate Bonds | 2024 Notes, 2026 Notes, and 2029 Notes

4.20%

Senior Unsecured Notes

Redemption option at par, period prior to maturity

1 month

Maximum | Corporate Bonds | 2024 Notes, 2026 Notes, and 2029 Notes

Senior Unsecured Notes

Redemption option at par, period prior to maturity

3 months

[1]	IMFT Member Debt was classified as current as of May 30, 2019 as a result of exercising our option to acquire Intel's interest in IMFT.

Debt - Debt Activity (Details)		1 Months Ended	3 Months Ended						9 Months Ended
Debt - Debt Activity (Details)	Mar. 13, 2019 USD ($)	Mar. 12, 2019 USD ($)	May 30, 2019 USD ($)	Feb. 28, 2019 USD ($)	Nov. 29, 2018 USD ($)	May 31, 2018 USD ($)	Mar. 01, 2018 USD ($)	Nov. 30, 2017 USD ($)	May 30, 2019 USD ($)	May 31, 2018 USD ($)
Extinguishment of Debt [Line Items]
Increase (Decrease) in Principal (conversions and issuances)									$ 728,000,000
Increase (Decrease) in Carrying Value									916,000,000
Increase (Decrease) in Cash (conversions and issuances)									144,000,000
Decrease in Equity			$ (5,000,000)	$ (336,000,000)	$ (36,000,000)	$ (985,000,000)	$ (252,000,000)	$ (204,000,000)	(377,000,000)
Gain (Loss) on debt prepayments, repurchases, and conversions			(317,000,000)			$ (168,000,000)			$ (386,000,000)	$ (386,000,000)
Convertible Debt
Extinguishment of Debt [Line Items]
Derivative, Term of Contract									20 days
Convertible Debt \| 2032D Notes
Extinguishment of Debt [Line Items]
Decrease in Principal									$ (10,000,000)
Increase (Decrease) in Carrying Value									(9,000,000)
Decrease in Cash									(35,000,000)
Decrease in Equity									(28,000,000)
Gain (Loss) on debt prepayments, repurchases, and conversions									2,000,000
Convertible Debt \| 2033F Notes
Extinguishment of Debt [Line Items]
Decrease in Principal									(43,000,000)
Increase (Decrease) in Carrying Value									(173,000,000)
Decrease in Cash									(184,000,000)
Decrease in Equity									(23,000,000)
Gain (Loss) on debt prepayments, repurchases, and conversions									12,000,000
Convertible Debt \| 2043G Notes
Extinguishment of Debt [Line Items]
Conversion rate (in shares per $1000 principal)		34.2936
Principal amount used In conversion rate		$ 1,000
Decrease in Principal									(1,019,000,000)
Increase (Decrease) in Carrying Value									(691,000,000)
Decrease in Cash	$ (1,430,000,000)								(1,426,000,000)
Decrease in Equity		$ (336,000,000)							(326,000,000)
Gain (Loss) on debt prepayments, repurchases, and conversions			$ (316,000,000)	$ (84,000,000)					(400,000,000)
Corporate Bonds \| 2024 Notes
Extinguishment of Debt [Line Items]
Increase (Decrease) in Principal (conversions and issuances)									600,000,000
Increase (Decrease) in Carrying Value									597,000,000
Increase in Cash									597,000,000
Corporate Bonds \| 2026 Notes
Extinguishment of Debt [Line Items]
Increase (Decrease) in Principal (conversions and issuances)									500,000,000
Increase (Decrease) in Carrying Value									497,000,000
Increase in Cash									497,000,000
Corporate Bonds \| 2029 Notes
Extinguishment of Debt [Line Items]
Increase (Decrease) in Principal (conversions and issuances)									700,000,000
Increase (Decrease) in Carrying Value									695,000,000
Increase in Cash									$ 695,000,000

Contingencies (Details) ¥ in Millions, $ in Millions			9 Months Ended
Contingencies (Details) ¥ in Millions, $ in Millions	Jun. 15, 2019 Claims	Jun. 13, 2019 Claims	May 30, 2019 CNY (¥) patent	May 30, 2019 USD ($) Claims
Pending Litigation \| Qimonda AG Inotera Share Purchase Proceedings
Loss Contingencies [Line Items]
Percentage of total Inotera shares subject to litigation (in hundredths)				18.00%
Loss contingency, judgment under appeal \| $				$ 1
Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Percent of annualized revenue derived from impacted products			1.00%
Patent Matters \| Pending Litigation \| MLC Intellectual Property, LLC.
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Patent Matters \| Pending Litigation \| Elm 3DS Innovations, LLC
Loss Contingencies [Line Items]
Number of patents allegedly infringed			13
Patent Matters \| Pending Litigation \| Innovative Memory Solutions, Inc. Complaint 1
Loss Contingencies [Line Items]
Number of patents allegedly infringed			8
Patent Matters \| Pending Litigation \| Innovative Memory Solutions, Inc. Complaint 2
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Patent Matters \| Pending Litigation \| Innovative Memory Solutions, Inc. Complaint 3
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Damages sought on alleged patent infringement \| ¥			¥ 1
Patent Matters \| Pending Litigation \| Fujian Jinhua Integrated Circuit Co., Ltd. Complaint 1
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Damages sought on alleged patent infringement \| ¥			¥ 98
Patent Matters \| Pending Litigation \| Fujian Jinhua Integrated Circuit Co., Ltd. Complaint 2
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Damages sought on alleged patent infringement \| ¥			¥ 98
Patent Matters \| Pending Litigation \| United Microelectronics Corporation Complaint 1
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Damages sought on alleged patent infringement \| ¥			¥ 90
Patent Matters \| Pending Litigation \| United Microelectronics Corporation Complaint 2
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Damages sought on alleged patent infringement \| ¥			¥ 90
Patent Matters \| Withdrawn \| United Microelectronics Corporation Complaint 3
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1
Damages sought on alleged patent infringement \| ¥			¥ 90
Antitrust Matters \| Pending Litigation \| Initial indirect DRAM Purchasers United States
Loss Contingencies [Line Items]
Number of pending complaints \| Claims				1
Antitrust Matters \| Pending Litigation \| Subsequent indirect DRAM Purchasers United States
Loss Contingencies [Line Items]
Number of pending complaints \| Claims				2
Antitrust Matters \| Pending Litigation \| Initial direct DRAM Purchasers United States
Loss Contingencies [Line Items]
Number of pending complaints \| Claims				1
Antitrust Matters \| Pending Litigation \| Subsequent direct DRAM Purchasers United States
Loss Contingencies [Line Items]
Number of pending complaints \| Claims				4
Antitrust Matters \| Pending Litigation \| DRAM Purchasers Canada
Loss Contingencies [Line Items]
Number of pending complaints \| Claims				6
Securities Matters \| Pending Litigation \| Shareholder Class Action Delaware Court
Loss Contingencies [Line Items]
Number of pending complaints \| Claims				1
Subsequent Event \| Securities Matters \| Pending Litigation \| Consolidated Shareholder Class Action New York Court
Loss Contingencies [Line Items]
Number of new or consolidated claims filed \| Claims	1
Subsequent Event \| Employment Matters \| Pending Litigation \| Employee Class Action
Loss Contingencies [Line Items]
Number of new or consolidated claims filed \| Claims		1

Equity - Common Stock Repurchase Authorization (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended	9 Months Ended
	May 30, 2019	May 30, 2019	May 31, 2018
Equity, Class of Treasury Stock [Line Items]
Payments to Acquire Treasury Stock		$ 2,727	$ 69
Repurchases Authorized May 2018 by the BOD
Equity, Class of Treasury Stock [Line Items]
Common Stock Repurchase, Authorized Amount	$ 10,000	$ 10,000
Treasury Shares Repurchased (in shares)	4	67
Payments to Acquire Treasury Stock	$ 157	$ 2,660

Equity - NCI and Consolidated VIE Disclosures (Details) - USD ($)
$ in Millions

3 Months Ended

6 Months Ended

9 Months Ended

Oct. 31, 2019

May 30, 2019

May 31, 2018

Apr. 30, 2020

Oct. 31, 2019

May 30, 2019

May 31, 2018

Aug. 30, 2018

Noncontrolling Interest Balance

$ 867

$ 870

IMFT sales to Intel at prices approximating cost

4,788

$ 7,797

18,536

$ 21,951

1,346

859

Noncontrolling Interest Balance

$ 867

$ 853

Noncontrolling Interest Percentage (in hundredths)

49.00%

Ownership interest in IMFT (in hundredths)

51.00%

Joint Venture Agreement, Terms, Partner Contribution Output Sharing Lag

8 months

Other Consolidated Entities

Noncontrolling Interest Balance

$ 0

$ 17

IM Flash Technologies, LLC | Intel

^[1]

865

IMFT sales to Intel at prices approximating cost

184

$ 114

531

$ 341

Forecast | IM Flash Technologies, LLC

Approximate amount expected to be paid to Intel to acquire its interest in IMFT

$ 1,400

Joint Venture Agreement, Terms, Intel Percentage of Lookback Supply from IMFT

50.00%

Joint Venture Agreement, Terms, Intel Supply Lookback Period

6 months

IMFT Member Debt | Convertible Debt

$ 858

^[2]

$ 858

^[2]

$ 0

[1]	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.
[2]	IMFT Member Debt was classified as current as of May 30, 2019 as a result of exercising our option to acquire Intel's interest in IMFT.

Equity - Consolidated VIE assets and liabilities (Details) - USD ($)
$ in Millions

May 30, 2019

Aug. 31, 2018

Aug. 30, 2018

Assets

Cash and equivalents

$ 5,157

$ 6,506

3,257

$ 5,592

5,478

Property, plant, and equipment

4,905

3,590

3,595

Other current assets

215

180

164

Total current assets

15,066

16,039

27,138

23,672

Other noncurrent assets

533

611

Total assets

46,288

43,376

Liabilities

Accounts payable and accrued expenses

3,494

4,374

Other current liabilities

1,346

859

557

517

521

Total current liabilities

5,397

5,754

Other noncurrent liabilities

3,563

3,777

417

$ 355

354

Total liabilities

9,999

10,112

Assets

Cash and equivalents

^[1]

184

^[1]

125

126

Property, plant, and equipment

^[1]

122

114

Other current assets

^[1]

Total current assets

^[1]

436

339

^[1]

2,352

2,641

Other noncurrent assets

^[1]

Total assets

^[1]

2,825

3,025

Liabilities

Accounts payable and accrued expenses

^[1]

106

138

Other current liabilities

^[1]

865

^[1]

Total current liabilities

^[1]

1,012

167

Other noncurrent liabilities

^[1]

1,064

^[1]

Total liabilities

^[1]

$ 1,089

$ 1,305

[1]	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Fair Value Measurements - Fair and Carrying Value (Details) - USD ($) $ in Millions	May 30, 2019	Aug. 30, 2018
Fair value disclosure [Line Items]
Carrying Value of Debt	$ 4,909	$ 4,636
Fair Value \| Level 2 \| Notes and MMJ Creditor Payments
Fair value disclosure [Line Items]
Fair Value of Notes and MMJ Creditor Payments	4,165	2,798
Fair Value \| Level 2 \| Convertible notes
Fair value disclosure [Line Items]
Fair Value of Convertible notes	643	3,124
Carrying Value \| Notes and MMJ Creditor Payments
Fair value disclosure [Line Items]
Carrying Value of Debt	4,072	2,741
Carrying Value \| Convertible notes
Fair value disclosure [Line Items]
Carrying Value of Debt	$ 189	$ 1,049

Derivative Instruments - Notional Amounts and Fair Values (Details)
shares in Millions, $ in Millions

9 Months Ended

May 30, 2019

USD ($)

Aug. 30, 2018

USD ($)

^[1]

$ 3

$ 14

Designated hedging instruments

^[2]

$ (12)

(190)

General maturity of currency forward contracts (in months)

12 months

Designated hedging instruments | Cash flow hedges | Currency forward

Notional Disclosures [Abstract]

Gross Notional Amount, Currency forwards

$ 190

538

^[1]

Not designated hedging instruments

^[2]

$ 0

(13)

^[1]

General maturity of currency forward contracts (in months)

^[2]

(177)

3 months

Not designated hedging instruments | Currency forward

Notional Disclosures [Abstract]

Gross Notional Amount, Currency forwards

$ 2,029

1,919

^[1]

Not designated hedging instruments | Convertible notes settlement obligation

^[2]

$ (12)

$ (10)

Notional Disclosures [Abstract]

Gross Notional Amount, Convertible notes settlement obligation (in shares) | shares

^[1]

$ 0